We're proud of the major role we played in the discovery and development of the AKT inhibitor, capivasertib. Professor David Barford's team carried out the fundamental research to reveal AKT's #3D structure (below) and how it is activated. Read more: icr.ac.uk/news-features/…

Amazing work done by Kyle@centromuir and colleages from Barford group @MRC_LMB!